These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23423582)
21. The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C Wang X; Yang N; Su J; Wu C; Liu S; Chang L; Plant LD; Meng X Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053271 [TBL] [Abstract][Full Text] [Related]
22. Identification and specificity studies of small-molecule ligands for SH3 protein domains. Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978 [TBL] [Abstract][Full Text] [Related]
23. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Xu XX; Yi T; Tang B; Lambeth JD Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023 [TBL] [Abstract][Full Text] [Related]
24. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain. Gouri BS; Swarup G Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926 [TBL] [Abstract][Full Text] [Related]
25. The crystal structure of the N-terminal SH3 domain of Grb2. Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246 [TBL] [Abstract][Full Text] [Related]
26. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343 [TBL] [Abstract][Full Text] [Related]
27. A specific intermolecular association between the regulatory domains of a Tec family kinase. Brazin KN; Fulton DB; Andreotti AH J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122 [TBL] [Abstract][Full Text] [Related]
29. Crystal Structure of the SH3 Domain of ASAP1 in Complex with the Proline Rich Motif (PRM) of MICAL1 Reveals a Unique SH3/PRM Interaction Mode. Jia X; Lin L; Xu S; Li L; Wei Z; Yu C; Niu F Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674928 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Kang SG; Zhou G; Yang P; Liu Y; Sun B; Huynh T; Meng H; Zhao L; Xing G; Chen C; Zhao Y; Zhou R Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15431-6. PubMed ID: 22949663 [TBL] [Abstract][Full Text] [Related]
31. A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C Li J; Chen L; Yan L; Gu Z; Chen Z; Zhang A; Zhao F Molecules; 2019 Jun; 24(13):. PubMed ID: 31252662 [TBL] [Abstract][Full Text] [Related]
32. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity. Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259 [TBL] [Abstract][Full Text] [Related]
33. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Wang J; Chen C; Li B; Yu H; Zhao Y; Sun J; Li Y; Xing G; Yuan H; Tang J; Chen Z; Meng H; Gao Y; Ye C; Chai Z; Zhu C; Ma B; Fang X; Wan L Biochem Pharmacol; 2006 Mar; 71(6):872-81. PubMed ID: 16436273 [TBL] [Abstract][Full Text] [Related]
34. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Plath K; Engel K; Schwedersky G; Gaestel M Biochem Biophys Res Commun; 1994 Sep; 203(2):1188-94. PubMed ID: 8093038 [TBL] [Abstract][Full Text] [Related]
36. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase. Renzoni DA; Pugh DJ; Siligardi G; Das P; Morton CJ; Rossi C; Waterfield MD; Campbell ID; Ladbury JE Biochemistry; 1996 Dec; 35(49):15646-53. PubMed ID: 8961927 [TBL] [Abstract][Full Text] [Related]
37. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2. VanderNoot VA; Fitzpatrick FA Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605 [TBL] [Abstract][Full Text] [Related]
38. The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction. Barnett P; Bottger G; Klein AT; Tabak HF; Distel B EMBO J; 2000 Dec; 19(23):6382-91. PubMed ID: 11101511 [TBL] [Abstract][Full Text] [Related]
39. The role of backbone motions in ligand binding to the c-Src SH3 domain. Wang C; Pawley NH; Nicholson LK J Mol Biol; 2001 Nov; 313(4):873-87. PubMed ID: 11697910 [TBL] [Abstract][Full Text] [Related]
40. Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities. Wu G; Gao XJ; Jang J; Gao X J Mol Model; 2016 Jul; 22(7):161. PubMed ID: 27316702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]